Clinical Trial

Predicting High-Flow Nasal Oxygen Failure at 30 Minutes Using a Physiology-Informed Dual-Domain Model

Study acronym: EFI-HFNO
Completed
View on ClinicalTrials.gov →
Summary
This prospective, single-center, two-stage translational study develops and validates a physiology-informed dual-domain model for ultra-early (30-minute) prediction of high-flow nasal oxygen (HFNO) failure in patients with acute hypoxemic respiratory failure. The study includes a physiological validation cohort (n=24) to anchor the EIT-derived Flow Index (EFI) as a marker of inspiratory effort, followed by a temporally separated clinical derivation cohort (n=57) and independent validation cohort (n=58). Candidate predictors are screened from 1,328 clinical features. The final dual-domain model integrates persistent physiological burden (baseline PaCO₂ and 30-minute EFI) with short-term dynamic adaptation (ΔRR and ΔSpO₂ over 30 minutes). The model's discrimination is tested prospectively without refitting.
Protocol Amendment History 6 changes
critical Trial completed 2026-06-18
critical Primary endpoint(s) modified 2026-06-18
notable Enrollment increased: 90 -> 164 participants 2026-06-18
minor Trial arms changed: 1 -> 5 2026-06-18
notable Primary completion pushed: 2025-12-31 -> 2026-03-31 2026-06-18
minor Completion pushed: 2026-02-01 -> 2026-03-31 2026-06-18
Trial Details
NCT Number NCT07366541
Lead Sponsor Ruijin Hospital
Conditions Acute Respiratory Failure, Electrical Impedance Tomography (EIT), High-Flow Nasal Oxygen Therapy
Enrollment 164 participants
Start Date 2025-05-01
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-17